Finding 30,000+ patients to enroll will be a massive task considering we already have vaccines that work well.
Many of the unvaccinated will be the vaccine hesitant. Good luck getting them into a trial.
What's more, assuming we get all the patients we need in the trial there still needs to be COVID floating around in the community to prove efficacy. The $25M you mentioned as the cost of the trial is probably missing a zero.
To be clear, I'm not trying to talk down the prospects, just trying to be realistic.
Finding 30,000+ patients to enroll will be a massive task...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.43M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 11.5¢ | $28.31K | 245.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 18704 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 367359 | 5 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IDT (ASX) Chart |